Skip to main content

Grifols S.A. has the Highest EPS Growth in the Drug Manufacturers Industry (GRFS, ELAN, ZOM, EBS, SXTC)

Below are the five companies in the Drug Manufacturers industry with the highest year-over-year expected earnings per share (EPS) growth rates.

Grifols S.A. ranks highest with EPS growth of 310.9%. Elanco Animal Health Incorporated is next with EPS growth of 197.1%. Zomedica Corp. ranks third highest with EPS growth of 180.6%.

Emergent Biosolutions Inc. follows with EPS growth of 149.9%, and China SXT Pharmaceuticals Inc. rounds out the top five with EPS growth of 56.2%.

InvestorBrandNetwork is monitoring the Biotechnology Industry for any potential shift so investors can protect gains.

Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts

To stay connected with our complimentary IBN Spotlights, please visit

About IBN (InvestorBrandNetwork)

IBN consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and Code Editorial Syndication to 5,000+ broadcast outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign and the NEW normal.

For more information on IBN, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.